Dr. Sura Surendranath Reddy has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
VIJAYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Sura Surendranath Reddy, on behalf of the Promoter and Promoter Group of Vijaya Diagnostic Centre Limited, has filed an annual declaration with NSE under SEBI's takeover regulations. The disclosure confirms that the promoters did not create any encumbrance — such as a pledge, lien, or charge — on their shares, either directly or indirectly, during the financial year ended March 31, 2025. No specific share quantities or details are mentioned because no encumbrance activity took place. The filing was copied to the Chairman of the Audit Committee as a standard practice. This is a routine annual compliance requirement for listed companies.
This is a neutral-to-mildly positive update for shareholders. It reassures investors that promoters have not pledged their holdings as collateral, signalling no immediate risk of forced share sales. However, since no new information is disclosed, the filing is unlikely to have any material effect on the stock price.